Human immunodeficiency virus type 1 employs the cellular dynein light chain 1 protein for reverse transcription through interaction with its integrase protein

Journal of Virology

Volumn 89, Issue 7, 2015, Pages 3497-3511

  Jayappa, Kallesh Danappa ^a   Ao, Zhujun ^a   Wang, Xiaoxia ^a,c   Mouland, Andrew J ^b   Shekhar, Sudhanshu ^a   Yang, Xi ^a   Yao, Xiaojian ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DYNEIN ADENOSINE TRIPHOSPHATASE; INTEGRASE; MATRIX PROTEIN; MICROSOMAL AMINOPEPTIDASE; PROTEIN DYNLL1; PROTEIN DYNLT1; UNCLASSIFIED DRUG; CYTOPLASMIC DYNEIN; DYNACTIN; DYNLL1 PROTEIN, HUMAN; DYNLT1 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS MUTANT; VIRUS REPLICATION; VIRUS UNCOATING; CELL LINE; DNA MUTATIONAL ANALYSIS; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

AMINO ACID MOTIFS; CELL LINE; CYTOPLASMIC DYNEINS; DNA MUTATIONAL ANALYSIS; DYNEINS; GENE KNOCKDOWN TECHNIQUES; HIV INTEGRASE; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTION; VIRUS UNCOATING;

EID: 84924778267     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03347-14     Document Type: Article

References (76)

1. Nisole S, Saib A. 2004. Early steps of retrovirus replicative cycle. Retrovirology 1:9. http://dx.doi.org/10.1186/1742-4690-1-9.
2. Jayappa KD, Ao Z, Yao X. 2012. The HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration. Int J Biochem Mol Biol 3:70-85.
3. Bieniasz PD. 2012. An overview of intracellular interactions between immunodeficiency viruses and their hosts. AIDS 26:1243-1254. http://dx.doi.org/10.1097/QAD.0b013e328353bd04.
4. Friedrich BM, Dziuba N, Li G, Endsley MA, Murray JL, Ferguson MR. 2011. Host factors mediating HIV-1 replication. Virus Res 161:101-114. http://dx.doi.org/10.1016/j.virusres.2011.08.001.
5. Kok KH, Lei T, Jin DY. 2009. siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication. Retrovirology 6:78. http://dx.doi.org/10.1186/1742-4690-6-78.
6. Van Maele B, Busschots K, Vandekerckhove L, Christ F, Debyser Z. 2006. Cellular co-factors of HIV-1 integration. Trends Biochemi Sci 31: 98-105. http://dx.doi.org/10.1016/j.tibs.2005.12.002.
7. Hamamoto S, Nishitsuji H, Amagasa T, Kannagi M, Masuda T. 2006. Identification of a novel human immunodeficiency virus type 1 integrase interactor, Gemin2, that facilitates efficient viral cDNA synthesis in vivo. J Virol 80:5670-5677. http://dx.doi.org/10.1128/JVI.02471-05.
8. Nishitsuji H, Hayashi T, Takahashi T, Miyano M, Kannagi M, Masuda T. 2009. Augmentation of reverse transcription by integrase through an interaction with host factor, SIP1/Gemin2 Is critical for HIV-1 infection. PLoS One 4:e7825. http://dx.doi.org/10.1371/journal.pone.0007825.
9. Mascarenhas AP, Musier-Forsyth K. 2009. The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors. FEBS J 276:6118-6127. http://dx.doi.org/10.1111/j.1742-4658.2009.07315.x.
10. Misumi S, Inoue M, Dochi T, Kishimoto N, Hasegawa N, Takamune N, Shoji S. 2010. Uncoating of human immunodeficiency virus type 1 re-quires prolyl isomerase Pin1. J Biol Chem 285:25185-25195. http://dx.doi.org/10.1074/jbc.M110.114256.
11. Aiken C. 2006. Viral and cellular factors that regulate HIV-1 uncoating. Curr Opin HIV AIDS 1:194-199. http://dx.doi.org/10.1097/01.COH.0000221591.11294.c1.
12. Fricke T, White TE, Schulte B, de Souza Aranha Vieira DA, Dharan A, Campbell EM, Brandariz-Nunez A, Diaz-Griffero F. 2014. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1. Retrovirology 11:68. http://dx.doi.org/10.1186/PREACCEPT-6453674081373986.
13. Guth CA, Sodroski J. 2014. Contribution of PDZD8 to stabilization of the human immunodeficiency virus type 1 capsid. J Virol 88:4612-4623. http://dx.doi.org/10.1128/JVI.02945-13.
14. Warren K, Warrilow D, Meredith L, Harrich D. 2009. Reverse transcriptase and cellular factors: regulators of HIV-1 reverse transcription. Viruses 1:873-894. http://dx.doi.org/10.3390/v1030873.
15. Dohner K, Wolfstein A, Prank U, Echeverri C, Dujardin D, Vallee R, Sodeik B. 2002. Function of dynein and dynactin in herpes simplex virus capsid transport. Mol Biol Cell 13:2795-2809. http://dx.doi.org/10.1091/mbc.01-07-0348.
16. Lo KW, Kogoy JM, Pfister KK. 2007. The DYNLT3 light chain directly links cytoplasmic dynein to a spindle checkpoint protein, Bub3. J Biol Chem 282:11205-11212. http://dx.doi.org/10.1074/jbc.M611279200.
17. Navarro C, Puthalakath H, Adams JM, Strasser A, Lehmann R. 2004. Egalitarian binds dynein light chain to establish oocyte polarity and maintain oocyte fate. Nat Cell Biol 6:427-435. http://dx.doi.org/10.1038/ncb1122.
18. Su Y, Qiao W, Guo T, Tan J, Li Z, Chen Y, Li X, Li Y, Zhou J, Chen Q. 2010. Microtubule-dependent retrograde transport of bovine immunodeficiency virus. Cell Microbiol 12:1098-1107. http://dx.doi.org/10.1111/j.1462-5822.2010.01453.x.
19. Mallik R, Gross SP. 2004. Molecular motors: strategies to get along. Curr Biol 14:R971-R982. http://dx.doi.org/10.1016/j.cub.2004.10.046.
20. Lukic Z, Dharan A, Fricke T, Diaz-Griffero F, Campbell EM. 2014. HIV-1 uncoating is facilitated by dynein and kinesin 1. J Virol 88:13613-13625. http://dx.doi.org/10.1128/JVI.02219-14.
21. Pawlica P, Berthoux L. 2014. Cytoplasmic dynein promotes HIV-1 uncoating. Viruses 6:4195-4211. http://dx.doi.org/10.3390/v6114195.
22. Arhel N. 2010. Revisiting HIV-1 uncoating. Retrovirology 7:96. http://dx.doi.org/10.1186/1742-4690-7-96.
23. Pawlica P, Le Sage V, Poccardi N, Tremblay MJ, Mouland AJ, Berthoux L. 2014. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5alpha-mediated restriction of retroviruses. J Virol 88:5661-5676. http://dx.doi.org/10.1128/JVI.03717-13.
24. Merino-Gracia J, Garcia-Mayoral MF, Rodriguez-Crespo I. 2011. The association of viral proteins with host cell dynein components during virus infection. FEBS J 278:2997-3011. http://dx.doi.org/10.1111/j.1742-4658.2011.08252.x.
25. Rapali P, Szenes A, Radnai L, Bakos A, Pal G, Nyitray L. 2011. DYNLL/LC8: a light chain subunit of the dynein motor complex and beyond. FEBS J 278:2980-2996. http://dx.doi.org/10.1111/j.1742-4658.2011.08254.x.
26. Poisson N, Real E, Gaudin Y, Vaney MC, King S, Jacob Y, Tordo N, Blondel D. 2001. Molecular basis for the interaction between rabies virus phosphoprotein P and the dynein light chain LC8: dissociation of dyneinbinding properties and transcriptional functionality of P. J Gen Virol 82: 2691-2696.
27. Raux H, Flamand A, Blondel D. 2000. Interaction of the rabies virus P protein with the LC8 dynein light chain. J Virol 74:10212-10216. http://dx.doi.org/10.1128/JVI.74.21.10212-10216.2000.
28. Tan GS, Preuss MA, Williams JC, Schnell MJ. 2007. The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription. Proc Natl Acad SciUS A 104:7229-7234. http://dx.doi.org/10.1073/pnas.0701397104.
29. Schneider MA, Spoden GA, Florin L, Lambert C. 2011. Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol 13:32-46. http://dx.doi.org/10.1111/j.1462-5822.2010.01515.x.
30. Schroer TA. 2004. Dynactin. Annu Rev Cell Dev Biol 20:759-779. http://dx.doi.org/10.1146/annurev.cellbio.20.012103.094623.
31. Alonso C, Miskin J, Hernaez B, Fernandez-Zapatero P, Soto L, Canto C, Rodriguez-Crespo I, Dixon L, Escribano JM. 2001. African swine fever virus protein p54 interacts with the microtubular motor complex through direct binding to light-chain dynein. J Virol 75:9819-9827. http://dx.doi.org/10.1128/JVI.75.20.9819-9827.2001.
32. Engelke MF, Burckhardt CJ, Morf MK, Greber UF. 2011. The dynactin complex enhances the speed of microtubule-dependent motions of adenovirus both towards and away from the nucleus. Viruses 3:233-253. http://dx.doi.org/10.3390/v3030233.
33. Ao Z, Fowke KR, Cohen EA, Yao X. 2005. Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import. Retrovirology 2:62. http://dx.doi.org/10.1186/1742-4690-2-62.
34. Ao Z, Huang G, Yao H, Xu Z, Labine M, Cochrane AW, Yao X. 2007. Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication. J Biol Chem 282:13456-13467. http://dx.doi.org/10.1074/jbc.M610546200.
35. Wang X, Ao Z, Chen L, Kobinger G, Peng J, Yao X. 2012. The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication. J Virol 86:3777-3786. http://dx.doi.org/10.1128/JVI.06594-11.
36. Ao Z, Danappa Jayappa K, Wang B, Zheng Y, Kung S, Rassart E, Depping R, Kohler M, Cohen EA, Yao X. 2010. Importin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replication. J Virol 84:8650-8663. http://dx.doi.org/10.1128/JVI.00508-10.
37. Ao Z, Jayappa KD, Wang B, Zheng Y, Wang X, Peng J, Yao X. 2012. Contribution of host nucleoporin 62 in HIV-1 integrase chromatin association and viral DNA integration. J Biol Chem 287:10544-10555. http://dx.doi.org/10.1074/jbc.M111.317057.
38. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59. http://dx.doi.org/10.1016/0378-1119(89)90358-2.
39. Berthoux L, Sebastian S, Muesing MA, Luban J. 2007. The role of lysine 186 in HIV-1 integrase multimerization. Virology 364:227-236. http://dx.doi.org/10.1016/j.virol.2007.02.029.
40. Jayappa KD, Ao Z, Yang M, Wang J, Yao X. 2011. Identification of critical motifs within HIV-1 integrase required for importin alpha3 interaction and viral cDNA nuclear import. J Mol Biol 410:847-862. http://dx.doi.org/10.1016/j.jmb.2011.04.011.
41. Zheng Y, Ao Z, Wang B, Jayappa KD, Yao X. 2011. Host protein Ku70 binds and protects HIV-1 integrase from proteasomal degradation and is required for HIV replication. J Biol Chem 286:17722-17735. http://dx.doi.org/10.1074/jbc.M110.184739.
42. Ao Z, Yao X, Cohen EA. 2004. Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system. J Virol 78:3170-3177. http://dx.doi.org/10.1128/JVI.78.6.3170-3177.2004.
43. Mouland AJ, Mercier J, Luo M, Bernier L, DesGroseillers L, Cohen EA. 2000. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J Virol 74:5441-5451. http://dx.doi.org/10.1128/JVI.74.12.5441-5451.2000.
44. Janas AM, Dong C, Wang JH, Wu L. 2008. Productive infection of human immunodeficiency virus type 1 in dendritic cells requires fusionmediated viral entry. Virology 375:442-451. http://dx.doi.org/10.1016/j.virol.2008.01.044.
45. Marechal V, Prevost MC, Petit C, Perret E, Heard JM, Schwartz O. 2001. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol 75:11166-11177. http://dx.doi.org/10.1128/JVI.75.22.11166-11177.2001.
46. Nobile C, Moris A, Porrot F, Sol-Foulon N, Schwartz O. 2003. Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN. J Virol 77:5313-5323. http://dx.doi.org/10.1128/JVI.77.9.5313-5323.2003.
47. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J. 2006. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci USA. 103:5514-5519. http://dx.doi.org/10.1073/pnas.0509996103.
48. Butler SL, Hansen MS, Bushman FD. 2001. A quantitative assay for HIV DNA integration in vivo. Nat Med 7:631-634. http://dx.doi.org/10.1038/87979.
49. Briones MS, Dobard CW, Chow SA. 2010. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core. J Virol 84: 5181-5190. http://dx.doi.org/10.1128/JVI.02382-09.
50. Dobard CW, Briones MS, Chow SA. 2007. Molecular mechanisms by which human immunodeficiency virus type 1 integrase stimulates the early steps of reverse transcription. J Virol 81:10037-10046. http://dx.doi.org/10.1128/JVI.00519-07.
51. Frankel AD, Young JA. 1998. HIV-1: fifteen proteins and an RNA. Annu Rev Biochem 67:1-25. http://dx.doi.org/10.1146/annurev.biochem.67.1.1.
52. Koh K, Miyaura M, Yoshida A, Sakurai A, Fujita M, Adachi A. 2000. Cell-dependent gag mutants of HIV-1 are crucially defective at the stage of uncoating/reverse transcription in non-permissive cells. Microbes Infect 2:1419-1423. http://dx.doi.org/10.1016/S1286-4579(00)01295-8.
53. Van Maele B, Debyser Z. 2005. HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins. AIDS Rev 7:26-43.
54. Zhu K, Dobard C, Chow SA. 2004. Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. J Virol 78:5045-5055. http://dx.doi.org/10.1128/JVI.78.10.5045-5055.2004.
55. Fan J, Zhang Q, Tochio H, Li M, Zhang M. 2001. Structural basis of diverse sequence-dependent target recognition by the 8 kDa dynein light chain. J Mol Biol 306:97-108. http://dx.doi.org/10.1006/jmbi.2000.4374.
56. Lo KW, Naisbitt S, Fan J S, Sheng M, Zhang M. 2001. The 8-kDa dynein light chain binds to its targets via a conserved (K/R)XTQT motif. J Biol Chem 276:14059-14066. http://dx.doi.org/10.1074/jbc.M010320200.
57. Rodriguez-Crespo I, Yelamos B, Roncal F, Albar JP, Ortiz de Montellano PR, Gavilanes F. 2001. Identification of novel cellular proteins that bind to the LC8 dynein light chain using a pepscan technique. FEBS Lett 503:135-141. http://dx.doi.org/10.1016/S0014-5793(01)02718-1.
58. Hehl EA, Joshi P, Kalpana GV, Prasad VR. 2004. Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins. J Virol 78:5056-5067. http://dx.doi.org/10.1128/JVI.78.10.5056-5067.2004.
59. Wilkinson TA, Januszyk K, Phillips ML, Tekeste SS, Zhang M, Miller JT, Le Grice SF, Clubb RT, Chow SA. 2009. Identifying and characterizing a functional HIV-1 reverse transcriptase-binding site on integrase. J Biol Chem 284:7931-7939. http://dx.doi.org/10.1074/jbc.M806241200.
60. Benison G, Nyarko A, Barbar E. 2006. Heteronuclear NMR identifies a nascent helix in intrinsically disordered dynein intermediate chain: implications for folding and dimerization. J Mol Biol 362:1082-1093. http://dx.doi.org/10.1016/j.jmb.2006.08.006.
61. Makokha M, Hare M, Li M, Hays T, Barbar E. 2002. Interactions of cytoplasmic dynein light chains Tctex-1 and LC8 with the intermediate chain IC74. Biochemistry 41:4302-4311. http://dx.doi.org/10.1021/bi011970h.
62. Nyarko A, Hare M, Hays TS, Barbar E. 2004. The intermediate chain of cytoplasmic dynein is partially disordered and gains structure upon binding to light-chain LC8. Biochemistry 43:15595-15603. http://dx.doi.org/10.1021/bi048451+.
63. Bao KK, Wang H, Miller JK, Erie DA, Skalka AM, Wong I. 2003. Functional oligomeric state of avian sarcoma virus integrase. J Biol Chem 278:1323-1327. http://dx.doi.org/10.1074/jbc.C200550200.
64. Faure A, Calmels C, Desjobert C, Castroviejo M, Caumont-Sarcos A, Tarrago-Litvak L, Litvak S, Parissi V. 2005. HIV-1 integrase crosslinked oligomers are active in vitro. Nucleic Acids Res 33:977-986. http://dx.doi.org/10.1093/nar/gki241.
65. Li M, Mizuuchi M, Burke TR, Jr., Craigie R. 2006. Retroviral DNA integration: reaction pathway and critical intermediates. EMBO J 25: 1295-1304. http://dx.doi.org/10.1038/sj.emboj.7601005.
66. Ren G, Gao K, Bushman FD, Yeager M. 2007. Single-particle image reconstruction of a tetramer of HIV integrase bound to DNA. J Mol Biol 366:286-294. http://dx.doi.org/10.1016/j.jmb.2006.11.029.
67. Lo KW, Kan HM, Chan LN, Xu WG, Wang KP, Wu Z, Sheng M, Zhang M. 2005. The 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulation. J Biol Chem 280:8172-8179. http://dx.doi.org/10.1074/jbc.M411408200.
68. Kardon JR, Vale RD. 2009. Regulators of the cytoplasmic dynein motor. Nat Rev Mol Cell Biol 10:854-865. http://dx.doi.org/10.1038/nrm2804.
69. Fassati A, Goff SP. 2001. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J Virol 75:3626-3635. http://dx.doi.org/10.1128/JVI.75.8.3626-3635.2001.
70. Miller MD, Farnet CM, Bushman FD. 1997. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol 71:5382-5390.
71. de Soultrait VR, Caumont A, Durrens P, Calmels C, Parissi V, Recordon P, Bon E, Desjobert C, Tarrago-Litvak L, Fournier M. 2002. HIV-1 integrase interacts with yeast microtubule-associated proteins. Biochim Biophys Acta 1575:40-48. http://dx.doi.org/10.1016/S0167-4781(02)00241-5.
72. Wang JY, Ling H, Yang W, Craigie R. 2001. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J 20:7333-7343. http://dx.doi.org/10.1093/emboj/20.24.7333.
73. Lu R, Ghory HZ, Engelman A. 2005. Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase. J Virol 79:10356-10368. http://dx.doi.org/10.1128/JVI.79.16.10356-10368.2005.
74. Williams JC, Roulhac PL, Roy AG, Vallee RB, Fitzgerald MC, Hendrickson WA. 2007. Structural and thermodynamic characterization of a cytoplasmic dynein light chain-intermediate chain complex. Proc Natl Acad Sci USA 104:10028-10033. http://dx.doi.org/10.1073/pnas.0703614104.
75. Sokolskaja E, Sayah DM, Luban J. 2004. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J Virol 78: 12800-12808. http://dx.doi.org/10.1128/JVI.78.23.12800-12808.2004.
76. Towers GJ, Hatziioannou T, Cowan S, Goff SP, Luban J, Bieniasz PD. 2003. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 9:1138-1143. http://dx.doi.org/10.1038/nm910.